Sectra AB (publ) (SECT-B.ST) stock analysis

In our weekly check, Sectra AB (publ) is graded B (A to F). Of 24 checks on debt, profit, cash flow and trend: 19 pass, warnings: 1, red flags: 4.

About Sectra AB (publ)

Sectra AB (publ) is a Healthcare company (Medical - Devices) based in Sweden, listed on STO as SECT-B.ST.

What our checks show for SECT-B.ST

Red flags

• The gross margin fell by 62.9 points, to 24.7%: costs are rising faster than prices.
• The price is 106 times earnings (P/E): the market already pays for a lot of future growth.
• The stock has fallen as much as 69% from a peak. Would you have held through that?
• Recovering from its deepest fall took about 5.3 years.

Warning signs

• Thinly traded (about 179 thousand shares a day): buying and selling can move the price.

Strengths

• Debt is low: 0.05x equity.
• Operating profit covers interest 149 times over.
• Operating cash flow is 1.77x net profit: the profit arrives as real cash.
• Analysts expect earnings per share to grow about 28.9% a year over the next years.
• Analysts expect revenue to grow about 17.1% a year over the next years.
• Analysts expect the net margin to improve by 4.5 points from today's 16.6%.

Next earnings report: 2026-11-25

Similar companies

BSX · GETI-B.ST · DEMANT.CO · EW · SHL.DE · SYK

Questions

What grade does Sectra AB (publ) (SECT-B.ST) have?

In our weekly check, Sectra AB (publ) is graded B (A to F). Of 24 checks on debt, profit, cash flow and trend: 19 pass, warnings: 1, red flags: 4. The grade is a risk check, not a buy or sell recommendation.

What are the main risks of SECT-B.ST stock?

This week's biggest flags for Sectra AB (publ): Gross margin falling, High P/E, Deep past fall. In total 5 of 24 checks show a warning or a red flag.

What does Sectra AB (publ) do?

Sectra AB (publ) is a Healthcare company (Medical - Devices) based in Sweden, listed on STO as SECT-B.ST.

When does Sectra AB (publ) report earnings next?

The next earnings report is expected on 2026-11-25. We re-run the checks every week, so the grade can change after it.

The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.

Updated 2026-10-31

Open the full analysis